ReviewCNS drugs2014
A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.
Martin A Katzman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this paperpooled itcites it